Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin

Progestin resistance is a major obstacle to treating early stage, well-differentiated endometrial cancer as well as recurrent endometrial cancer. The mechanism behind the suboptimal response to progestin is not well understood. The PTEN tumor suppressor gene is frequently mutated in type I endometri...

Descripción completa

Detalles Bibliográficos
Autores principales: Pant, Alok, Lee, Irene I., Lu, Zhenxiao, Rueda, Bo R., Schink, Julian, Kim, J. Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404036/
https://www.ncbi.nlm.nih.gov/pubmed/22911820
http://dx.doi.org/10.1371/journal.pone.0041593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404036/
https://www.ncbi.nlm.nih.gov/pubmed/22911820
http://dx.doi.org/10.1371/journal.pone.0041593

Ejemplares similares